🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Liver Cancer

Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC NCT06553885Phase 21 site📍 Tampa H. Lee Moffitt Cancer Center and Research Institute · Tests: Enfortumab Vedotin Iparomlimab and Tuvonralimab as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With High Risk of Recurrence NCT06954116Phase 21 site📍 Wuhan Tongji Hospital · Tests: Iparomlimab and Tuvonralimab (QL1706), Partial hepatectomy RAdiation SEgmentectomy With REsin Microspheres (RASEREM) Study NCT07345247n/a20 sites📍 Adana📍 Adana📍 Adana Ankara University Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease NCT06607458Phase 220 sites📍 Duarte📍 Santa Monica📍 Miami Delcath Systems Inc. · Tests: Melphalan/HDS Followed by Consolidation Treatment with Trifluridine-tipiracil plus Bevacizumab, Trifluridine-tipiracil … Can Hepatic-splenic Elastography Predict the Risk of Hepatocellular Recurrence After Radiofrequency Ablation? NCT06777017n/a1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health Abbreviated MRI Using Gadoxetic Acid Versus CT for Surveillance of Recurrent HCC After Curative Treatment NCT06537193NA1 site📍 Seoul Asan Medical Center · Tests: AMRI, CT Safety and Efficacy of Tremelimumab+Durvalumab(MEDI4736)+TACE in Unresectable Hepatocellular Carcinoma NCT06911255Phase 1, Phase 21 site📍 Seoul Yoon Jun Kim · Tests: Tremelimumab Plus Durvalumab (MEDI4736), Transarterial chemoembolization (TACE) Advanced Therapies for Liver Metastases NCT04622423n/a1 site📍 Milan IRCCS San Raffaele A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations NCT05503797Phase 270 sites📍 Beverly Hills📍 San Francisco📍 Westwood, Los Angeles Fore Biotherapeutics · Tests: Plixorafenib 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors NCT07557225NA1 site📍 Beijing Peking University First Hospital · Tests: 18F-T2 PET/CT Application of ICG@HSA Complexes in Fluorescence Image-Guided Laparoscopic Anatomical Liver Resection NCT06219096NA1 site📍 Chengdu West China Hospital · Tests: NIF image-guided laparoscopic anatomical liver resection with the novel ICG@HSA administration, NIF image-guided laparo… A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC) NCT05657873Phase 29 sites📍 Miami📍 Basking Ridge📍 Middletown Memorial Sloan Kettering Cancer Center · Tests: L-SABR, Anti-PD-(L)1 based immunotherapy, Platinum based chemotherapy Recurrent Liver Cancer: Reconceptualization and Reevaluation NCT06430983n/a1 site📍 Nanjing Nanjing Medical University Precision Navigation to Improve Community Cancer Screening Participation NCT07676383NA3 sites📍 Huaihua📍 Shaoyang📍 Yongzhou Hunan Cancer Hospital · Tests: Precision Navigation Intervention, Usual Health Education Study on the Quantitative Assessment of the Risk of Hepatocellular Carcinoma in Patients With Chronic Liver Disease Using Multi-parameter Magnetic Resonance Imaging NCT06060769n/a1 site📍 Zhuhai Fifth Affiliated Hospital, Sun Yat-Sen University Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC NCT06726161Phase 1, Phase 213 sites📍 Birmingham📍 Phoenix📍 Orange RayzeBio, Inc. · Tests: RYZ811, RYZ801 SHIELD: Sorafenib Hand-foot Syndrome Inhibition With Pre-Emptive Local Delivery of Topical Indomethacin NCT07560566Phase 21 site📍 Taipei National Taiwan University Hospital · Tests: Topical Indomethacin 177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer NCT07145177Phase 11 site📍 San Francisco University of California, San Francisco · Tests: 177Lu-PSMA-617, Ablation, Trans-arterial chemoembolization (TACE), Positron Emission Tomography (PET)/Computerized tomo… Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Hepatocellular Carcinoma Recurrence Surveillance NCT06653062n/a1 site📍 Wuhan Tongji Hospital · Tests: Plasma and Tumor Tissue Mitochondrial DNA (mtDNA) Mutation Analysis 4D-MRI for Precision Medicine NCT04657042n/a1 site📍 Charlottesville University of Virginia · Tests: Magnetic Resonance Imaging A Study on the Efficacy and Safety of Multi-mode Ablation Combined With Systemic Therapy in the Treatment of CRCLM NCT06590259Phase 21 site📍 Shanghai Shanghai 6th People's Hospital · Tests: Multi-mode tumor treatment system, Sintilimab+mFOLFOX6 or FOLFIRI+bevacizumab or cetuximab Standard Versus Radiobiologically-Guided Dose Selected SBRT in Liver Cancer NCT04745390NA1 site📍 London London Health Sciences Centre Research Institute OR Lawson … · Tests: Radiation therapy LIver TrAnspLantation for Non-resectable Peri-HIlar cholangioCArcinoma (LITALHICA) NCT06125769NA1 site📍 Padova Azienda Sanitaria Ospedaliera · Tests: Liver transplantation Treatment Selection by 3D Bioprinting Liver Model to Prevent Liver Cancer Recurrence NCT07839767n/a1 site📍 Hong Kong The University of Hong Kong · Tests: Liver-in-cube testing A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) NCT06330064Phase 1, Phase 2120 sites📍 Los Angeles📍 Los Angeles📍 Whittier Daiichi Sankyo · Tests: Ifinatamab deruxtecan Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers NCT04221893NA2 sites📍 San Francisco📍 Walnut Creek University of California, San Francisco · Tests: Radiation Therapy (RT) Tebentafusp-tebn With LDT in Metastatic UM NCT06626516Phase 1, Phase 21 site📍 Philadelphia Thomas Jefferson University · Tests: Tebentafusp-Tebn, GM-CSF (Sargramostim), BCNU NWRD06 DNA Plasmid for HCC After Curative Resection. NCT07324304Phase 26 sites📍 Beijing📍 Beijing📍 Beijing Newish Technology (Beijing) Co., Ltd. · Tests: NWRD06 administered by electroporation Study of GV20-0251 in Participants With Solid Tumor Malignancies NCT07070518Phase 1, Phase 23 sites📍 Beijing📍 Beijing📍 Shanghai GV20 Therapeutics · Tests: GV20-0251
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy